Moderna Inc (MRNA)
Return on total capital
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | -4,239,000 | -2,665,000 | 513,000 | 4,827,000 | 9,420,000 | 13,250,000 | 15,642,000 | 16,257,000 | 13,296,000 | 7,611,000 | 3,818,000 | 634,000 | -763,000 | -618,556 | -514,320 | -536,029 | -546,670 | -569,145 | ||
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 13,854,000 | 13,455,000 | 16,949,000 | 18,863,000 | 19,123,000 | 17,992,000 | 17,985,000 | 17,075,000 | 14,145,000 | 10,124,000 | 6,704,000 | 3,838,000 | 2,561,000 | 2,760,000 | 2,947,000 | 1,641,000 | 1,175,000 | 1,248,190 | 1,334,960 | 1,442,320 |
| Return on total capital | -30.60% | -19.81% | 3.03% | 25.59% | 49.26% | 73.64% | 86.97% | 95.21% | 94.00% | 75.18% | 56.95% | 16.52% | -29.79% | -22.41% | -17.45% | -32.66% | -46.53% | -45.60% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $-4,239,000K ÷ ($—K + $13,854,000K)
= -30.60%
Return on total capital is a key financial ratio that indicates how effectively a company is generating profits from its total invested capital. Looking at Moderna Inc's return on total capital data over the past eight quarters, we can observe a fluctuating trend.
In Q1 2023, the return on total capital was significantly high at 24.32%, suggesting that Moderna was able to generate a considerable return on its total capital investments. This was a positive sign for the company's profitability and efficient use of capital.
However, in the subsequent quarters, the return on total capital decreased, reaching a low of -29.38% in Q4 2023. This decline indicates that Moderna's profitability relative to its total capital investment decreased significantly, possibly due to changes in the company's financial performance or capital structure.
Overall, the fluctuating trend in Moderna Inc's return on total capital over the past eight quarters suggests that the company's ability to generate profits from its total invested capital has been variable. Further analysis of the underlying factors impacting profitability and capital efficiency would be needed to gain a deeper understanding of the company's financial performance.
Peer comparison
Dec 31, 2023